William M. Mcclements - Net Worth and Insider Trading
William M. Mcclements Net Worth
The estimated net worth of William M. Mcclements is at least $20,725 dollars as of 2024-04-25. William M. Mcclements is the Head of Corporate Operations of Merrimack Pharmaceuticals Inc and owns about 1,407 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $20,725. Details can be seen in William M. Mcclements's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William M. Mcclements has not made any transactions after 2016-02-29 and currently still holds the listed stock(s).
Transaction Summary of William M. Mcclements
William M. Mcclements Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William M. Mcclements owns 1 companies in total, including Merrimack Pharmaceuticals Inc (MACK) .
Click here to see the complete history of William M. Mcclements’s form 4 insider trades.
Insider Ownership Summary of William M. Mcclements
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2016-02-29 | SVP of Corporate Operations |
William M. Mcclements Latest Holdings Summary
William M. Mcclements currently owns a total of 1 stock. William M. Mcclements owns 1,407 shares of Merrimack Pharmaceuticals Inc (MACK) as of February 29, 2016, with a value of $20,725.
Latest Holdings of William M. Mcclements
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2016-02-29 | 1,407 | 14.73 | 20,725 |
Holding Weightings of William M. Mcclements
William M. Mcclements Form 4 Trading Tracker
According to the SEC Form 4 filings, William M. Mcclements has made a total of 0 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years. The most-recent trade in Merrimack Pharmaceuticals Inc is the acquisition of 200 shares on February 29, 2016, which cost William M. Mcclements around $11,440.
Insider Trading History of William M. Mcclements
- 1
William M. Mcclements Trading Performance
GuruFocus tracks the stock performance after each of William M. Mcclements's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William M. Mcclements is 8.98%. GuruFocus also compares William M. Mcclements's trading performance to market benchmark return within the same time period. The performance of stocks bought by William M. Mcclements within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William M. Mcclements's insider trading performs compared to the benchmark.
Performance of William M. Mcclements
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 40.93 | 8.98 | -17.96 | -48.52 | -56.6 | -53.05 |
| Relative Return to S&P 500(%) | 34.58 | 0.35 | -30.8 | -72.45 | -74.29 | -66.25 |
William M. Mcclements Ownership Network
Ownership Network List of William M. Mcclements
Ownership Network Relation of William M. Mcclements
William M. Mcclements Owned Company Details
What does Merrimack Pharmaceuticals Inc do?
Who are the key executives at Merrimack Pharmaceuticals Inc?
William M. Mcclements is the SVP of Corporate Operations of Merrimack Pharmaceuticals Inc. Other key executives at Merrimack Pharmaceuticals Inc include director & other: See Remarks Eric Andersen , director & President Gary L Crocker , and director & other: See Remarks Noah G. Levy .
Merrimack Pharmaceuticals Inc (MACK) Insider Trades Summary
Over the past 18 months, William M. Mcclements made no insider transaction in Merrimack Pharmaceuticals Inc (MACK). Other recent insider transactions involving Merrimack Pharmaceuticals Inc (MACK) include a net purchase of 942,726 shares made by Eric Andersen , a net purchase of 100,000 shares made by Noah G. Levy , and a net purchase of 4,156 shares made by Ana Radeljevic .
In summary, during the past 3 months, insiders sold 0 shares of Merrimack Pharmaceuticals Inc (MACK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merrimack Pharmaceuticals Inc (MACK) were sold and 1,050,882 shares were bought by its insiders, resulting in a net purchase of 1,050,882 shares.
Merrimack Pharmaceuticals Inc (MACK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merrimack Pharmaceuticals Inc Insider Transactions
William M. Mcclements Mailing Address
Above is the net worth, insider trading, and ownership report for William M. Mcclements. You might contact William M. Mcclements via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
